Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
PHASE1
This phase I trial studies the safety of personalized neo-antigen peptide v...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access
N/A
This study evaluates whether healthcare providers without specialized ultra...
Status
Terminated
Location
Cleveland Clinic, Cardiovascular Medicine Department
Start Date
2025-07-25
Trial ID
NCT07155434
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
PHASE3
This phase III trial tests how well surgery plus chemotherapy compared to s...
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
PHASE2
This phase II MATCH screening and multi-sub-trial studies how well treatmen...